Reported about 7 hours ago
Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, aiming to address the company's stagnant performance despite a favorable response to its COVID vaccine. Following this investment, Pfizer's stock rose over 4%. CEO Albert Bourla has faced challenges in convincing Wall Street of the company's value, as it has been trading within a tight range and is facing potential revenue constraints from patent expirations.
Source: YAHOO